Live from the NIH registry
Studies recruiting near Lafayette right now
Top 25 of 34 recruiting studies, sorted by proximity — each links to its official registry page
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 3
Interventional 360 participants sought
Franciscan Saint Elizabeth Health - Lafayette East — Lafayette, Indiana (1.5 mi)
· Sponsor: National Cancer Institute (NCI)
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
Cancer
Phase 1, Phase 2
Interventional 130 participants sought
Horizon Oncology Research — Lafayette, Indiana (1.5 mi)
· Sponsor: MBrace Therapeutics
A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS.
Hidradenitis Suppurativa
Phase 2
Interventional 240 participants sought
Options Research Group — West Lafayette, Indiana (3.2 mi)
· Sponsor: Pfizer
Effects of Replacing High Protein Foods in People With Chronic Kidney Disease
Chronic Kidney Disease Stage 3
N/A
Interventional 15 participants sought
Purdue University — West Lafayette, Indiana (3.2 mi)
· Sponsor: Indiana University
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Non Small Cell Lung Cancer
Phase 3
Interventional 780 participants sought
Indiana University Health Arnett Cancer Center ( Site 0076) — Lafayette, Indiana (1.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
Addressing Tetrachloroethylene Exposure in an Impacted Community
Vapors; Inhalation, Cancer
N/A
Interventional 510 participants sought
Purdue University — West Lafayette, Indiana (3.2 mi)
· Sponsor: Purdue University
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma
Phase 3
Interventional 1,210 participants sought
Franciscan Saint Elizabeth Health - Lafayette East — Lafayette, Indiana (1.5 mi)
· Sponsor: National Cancer Institute (NCI)
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
Hidradenitis Suppurativa (HS)
Phase 3
Interventional 600 participants sought
Investigative Site US064 — West Lafayette, Indiana (3.2 mi)
· Sponsor: Incyte Corporation
Retrieval-Based Word Learning in Developmental Language Disorder During Book Reading II
Developmental Language Disorder and Language Impairment, Specific Language Impairment
N/A
Interventional 32 participants sought
Purdue University — West Lafayette, Indiana (3.2 mi)
· Sponsor: Purdue University
A Study Evaluating the Safety and Efficacy of HB0036 in Subjects With Advanced Solid Tumors
Advanced Solid Tumor, NSCLC
Phase 1, Phase 2
Interventional 80 participants sought
Horizon Oncology — Lafayette, Indiana (1.5 mi)
· Sponsor: Shanghai Huaota Biopharmaceutical Co., Ltd.
Retrieval-based Word Learning in Developmental Language Disorder: Adaptive Retrieval Schedule
Developmental Language Disorder, Specific Language Impairment
N/A
Interventional 32 participants sought
Purdue University — West Lafayette, Indiana (3.2 mi)
· Sponsor: Purdue University
Wearable Biofeedback for Swallowing Disorders Rehabilitation in Stroke and Parkinson Disease
Dysphagia, Stroke
Phase 2
Interventional 120 participants sought
Purdue University — West Lafayette, Indiana (3.2 mi)
· Sponsor: University of Illinois at Urbana-Champaign
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Triple Negative Breast Cancer
Phase 3
Interventional 1,514 participants sought
IU Health Arnett Hospital — Lafayette, Indiana (1.5 mi)
· Sponsor: Gilead Sciences
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Lumbar Spinal Stenosis
N/A
Observational 8,000 participants sought
Lafayette Pain Care — Lafayette, Indiana (1.5 mi)
· Sponsor: Stryker Instruments
Slowly Digestible Carbohydrates for GLP-1 Secretion
Blood Glucose, GLP-1
N/A
Interventional 19 participants sought
Clinical Research Center at Purdue University — West Lafayette, Indiana (3.2 mi)
· Sponsor: Purdue University
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Cardiotoxicity, HER2/Neu Positive
Phase 3
Interventional 491 participants sought
Franciscan Saint Elizabeth Health - Lafayette East — Lafayette, Indiana (1.5 mi)
· Sponsor: SWOG Cancer Research Network
Heat Therapy in Type 2 Diabetes
Type 2 Diabetes
Phase 1
Interventional 24 participants sought
Purdue University — West Lafayette, Indiana (3.2 mi)
· Sponsor: Purdue University
The Food Environment, Microbial Cysteine Metabolism, and Cancer Disparities
Colorectal Cancer
N/A
Interventional 40 participants sought
Purdue Clinical Research Center — West Lafayette, Indiana (3.2 mi)
· Sponsor: Purdue University
Impact of Native Chicory Inulin on Change and Persistence of Gut Microbiota
Healthy
N/A
Interventional 52 participants sought
Purdue University — West Lafayette, Indiana (3.2 mi)
· Sponsor: Purdue University
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
Atopic Dermatitis
Phase 3
Interventional 200 participants sought
Options Research Group /ID# 264564 — West Lafayette, Indiana (3.2 mi)
· Sponsor: AbbVie
A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata
Alopecia Areata (AA)
Phase 1, Phase 2
Interventional 24 participants sought
Options Research Group — West Lafayette, Indiana (3.2 mi)
· Sponsor: Aldena Therapeutics
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy
Hidradenitis Suppurativa
Phase 3
Interventional 1,328 participants sought
Options Research Group /ID# 254537 — West Lafayette, Indiana (3.2 mi)
· Sponsor: AbbVie
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
Non-small Cell Lung Cancer
Phase 3
Interventional 675 participants sought
Indiana University Health Arnett Cancer Center ( Site 0116) — Lafayette, Indiana (1.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
Health Effects of Grain Foods in Adults
High Whole Grain and Low Sugar, Medium Whole Grain and Low Sugar
N/A
Interventional 120 participants sought
Purdue University — West Lafayette, Indiana (3.2 mi)
· Sponsor: Purdue University
Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic Malignancies
Relapsed or Refractory Hematologic Malignancies
Phase 1
Interventional 42 participants sought
Vanda Investigational Site — Lafayette, Indiana (1.5 mi)
· Sponsor: Vanda Pharmaceuticals